Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: A pathological and virological study

References

• IARC Cancer Base No. 5. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence WorldwideVersion 1.0. IARC Press, Lyon 2001
   Google Scholar
• Correa P, O'Conor G T. Epidemiologic patterns of Hodgkin's disease. Int J Cancer 1971; 8: 192–201
   PubMed Web of Science ®Google Scholar
• Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease. N Engl J Med 1981; 304: 135–140
   PubMed Web of Science ®Google Scholar
• Mueller N, Evans A, Harris N L, Comstock G W, Jellum E, Magnus K, et al. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989; 320: 689–695
   PubMed Web of Science ®Google Scholar
• Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Muller-Lantzsch N, et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 1991; 88: 4766–4770
   PubMed Web of Science ®Google Scholar
• Pallesen G, Hamilton-Dutoit S J, Rowe M, Young L S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320–322
   PubMed Web of Science ®Google Scholar
• Delsol G, Brousset P, Chittal S, Rigal-Huguet F. Correlation of the expression of Epstein-Barr virus-latent membrane protein and in situ hybridization with biotinylated Bam HI-W probes in Hodgkin's disease. Am J Pathol 1992; 140: 247–253
   PubMed Web of Science ®Google Scholar
• Khan G, Norton A J, Slavin G. Epstein-Barr virus in Hodgkin disease relation to age and subtype. Cancer 1993; 71: 3124–3129
   PubMed Web of Science ®Google Scholar
• Ambinder R F, Browning P J, Lorenzana I, Leventhal B G, Cosenza H, Mann R B, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993; 81: 462–467
   PubMed Web of Science ®Google Scholar
• Pinkus G S, Lones M, Shintaku I P, Said J W. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease. Mod Pathol 1994; 7: 456–461
   Google Scholar
• Hayashi K, Chen W G, Chen Y Y, Bacchi M M, Bachi C E, Alvarenga M, et al. Deletion of Epstein-Barr virus latent membrane protein-1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion. Hum Pathol 1997; 28: 1408–1414
   PubMed Web of Science ®Google Scholar
• Belkaid M L, Briere J, Djebbara Z, Beldjord K, Andrieu J M, Colonna P. Comparison of Epstein-Barr virus markers in Reed-sternberg cells in adult Hodgkin's disease tissues from an industrialized and a developing country. Leuk Lymphoma 1995; 17: 163–168
   PubMed Web of Science ®Google Scholar
• Enblad G, Sandvej K, Sundstrom C, Pallesen G, Glimelius B. Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Acta Oncol 1999; 38: 425–429
   PubMed Web of Science ®Google Scholar
• Armstrong A A, Alexander F E, Cartwright R, Angus B, Krajewski A S, Wright D H, et al. Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 1998; 12: 1272–1276
   PubMed Web of Science ®Google Scholar
• Herbst H, Steinbrecher E, Niedobitek G, Young L S, Brooks L, Muller-Lantzsch N, et al. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 1992; 80: 484–491
   PubMed Web of Science ®Google Scholar
• Hummel M, Anagnostopoulos I, Dallenbach F, Korbjuhn P, Dimmler C, Stein H. EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol 1992; 82: 689–694
   PubMed Web of Science ®Google Scholar
• Niedobitek G, Rowlands D C, Young L S, Herbst H, Williams A, Hall P, et al. Overexpression of p53 in Hodgkin's disease: lack of correlation with Epstein-Barr virus infection. J Pathol 1993; 169: 207–212
   PubMed Web of Science ®Google Scholar
• Jarrett A F, Armstrong A A, Alexander E. Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 1996; 7(Suppl 4)5–10
   PubMed Web of Science ®Google Scholar
• Macak J, Habanec B, Fabian P. Detection of Epstein-Barr virus in Hodgkin's lymphoma (patients in the Czech Republic). Neoplasma 2000; 47: 156–161
   PubMed Web of Science ®Google Scholar
• Leoncini L, Spina D, Nyong'o A, Abinya O, Minacci C, Disanto A, et al. Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy. Int J Cancer 1996; 65: 781–784
   PubMed Web of Science ®Google Scholar
• Chang K L, Albujar P F, Chen Y Y, Johnson R M, Weiss L M. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 1993; 81: 496–501
   PubMed Web of Science ®Google Scholar
• Zarate-Osorno A, Roman L N, Kingma D W, Meneses-Garcia A, Jaffe E S. Hodgkin's disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype. Cancer 1995; 75: 1360–1366
   PubMed Web of Science ®Google Scholar
• Dirnhofer S, Angeles-Angeles A, Ortiz-Hidalgo C, Reyes E, Gredler E, Krugmann J, et al. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Hum Pathol 1999; 30: 781–787
   PubMed Web of Science ®Google Scholar
• Weinreb M, Day P J, Niggli F, Green E K, Nyong'o A O, Othieno-Abinya N A, et al. The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya. Blood 1996; 87: 3828–3836
   PubMed Web of Science ®Google Scholar
• Kusuda M, Toriyama K, Kamidgo N O, Itakura H. A comparison of epidemiologic, histologic, and virologic studies on Hodgkin's disease in western Kenia and Nagasaki, Japan. Am J Trop Med 1998; 59: 801–807
   PubMed Web of Science ®Google Scholar
• Korbi S, Trimeche M, Sriha B, Yacoubi M T, Hmissa S, Mokni M, et al. Epstein-Barr virus in Hodgkin's disease: the example of central Tunisia. Ann Pathol 2002; 22: 96–101
   PubMed Web of Science ®Google Scholar
• Weiss L M, Movahed L A, Warnke R A, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• Weiss L, Strickler J G, Warnke P A, Purtilo D T, Sklar J. Epstein-Barr virus-DNA, in tissus of Hodgkin's disease. Am J of Pathol 1987; 129: 86–91
   PubMed Web of Science ®Google Scholar
• Vasef M A, Kamel O W, Chen Y Y, Medeiros L J, Weiss L M. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 1995; 147: 1408–1415
   PubMed Web of Science ®Google Scholar
• Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831–840
   PubMed Web of Science ®Google Scholar
• Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 products infected B-cells from programmed cell death. Cell 1991; 65: 1107–1115
   PubMed Web of Science ®Google Scholar
• Chen M L, Tsai C N, Liang C L, Shu C H, Huang C R, Sulitzeanu D, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992; 7: 2131–2140
   PubMed Web of Science ®Google Scholar
• Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, et al. Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937–2942
   PubMed Web of Science ®Google Scholar
• Sandvej K, Peh S C, Andresen B S, Pallesen G. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994; 84: 4053–4060
   PubMed Web of Science ®Google Scholar
• Santon A, Martin C, Manzanal A I, Preciado M V, Bellas C. Paediatric Hodgkin's disease in Spain: association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections. Br J Haematol 1998; 103: 129–136
   PubMed Web of Science ®Google Scholar
• Kingma D W, Weiss W B, Jaffe E S, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242–251
   PubMed Web of Science ®Google Scholar
• Bellas C, Santon A, Manzanal A, Campo E, Martin C, Acevedo A, et al. Pathological, immunological, and molecular features of Hodgkin's disease association with HIV infection. Comparison with ordinary Hodgkin's disease. Am J Surg Pathol 1996; 20: 1520–1524
   PubMed Web of Science ®Google Scholar
• Dolcetti R, Zancai P, De Re P, Gloghini A, Bigoni B, Pivetta B, et al. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 1997; 89: 1723–1731
   PubMed Web of Science ®Google Scholar
• Trimeche M, Korbi S, Ziadi S, Amara K, Boniver J, de Leval L. Molecular characterization of Epstein-Barr virus associated with classical Hodgkin's lymphoma in Tunisia: prevalence of the LMP1 oncogene deletions and A and B viruses strains. Ann Biol Clin 2005; 63: 193–199
   PubMed Web of Science ®Google Scholar
• Dolcetti R, Quaia M, Gloghini A, De Re V, Zancai P, Cariati R, et al. Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease. Int J Cancer 1999; 80: 240–249
   PubMed Web of Science ®Google Scholar
• Rickinson A B, Young L S, Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 1987; 61: 1310–1317
   PubMed Web of Science ®Google Scholar
• Boyle M J, Vasak E, Tschuchnigg M, Turner J J, Sculley T, Penny R, et al. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood 1993; 81: 468–474
   PubMed Web of Science ®Google Scholar
• Boyle M J, Sewell W A, Sculley T B, Apolloni A, Turner J J, Swanson C E, et al. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 1991; 78: 3004–3011
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Harris N L, Stein H, Vardiman J W. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001; 352
   Google Scholar
• Lukes R J, Butler J J. The pathology and nomenclature of Hodgkin's disease. Cancer Research 1966; 26: 1063–1083
   PubMed Web of Science ®Google Scholar
• Carbone P P, Kaplan H S, Musshoff K, Smithiers D W, Tubiana M. Report of the committee on Hodgkin's disease staging. Cancer Res 1966; 31: 1860–1861
   Google Scholar
• de Leval L, Vivario M, De Prijck B, Zhou Y, Boniver J, Harris N L, et al. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection. Am J Surg Pathol 2004; 28: 679–686
   PubMed Web of Science ®Google Scholar
• Edinger J W, Bonneville M, Scotet E, Houssaint E, Schumacher H R, Posnett D N. EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific T cell clones. J Immunol 1999; 162: 3694–3701
   PubMed Web of Science ®Google Scholar
• Tacyildiz N, Cavdar A O, Ertem U, Oksal A, Kutluay L, Uluoglu O, et al. Unusually high frequency of a 69-bp deletion within the carboxy terminus of the LMP-1 oncogene of Epstein-Barr virus detected in Burkitt's lymphoma of Turkish children. Leukemia 1998; 12: 1796–1805
   PubMed Web of Science ®Google Scholar
• Lin J. -C, Lin S C, De B K, Chan W P, Evatt B L. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Blood 1993; 81: 3372–3381
   PubMed Web of Science ®Google Scholar
• Weinreb M, Day P J, Murray P G, Raafat F, Crocker J, Parkes S E, et al. Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells. J Pathol 1992; 168: 365–369
   PubMed Web of Science ®Google Scholar
• Brousset P, Rochaix P, Chittal S, Rubie H, Robert A, Delsol G. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993; 23: 189–191
   PubMed Web of Science ®Google Scholar
• Murray P G, Young L S, Rowe M, Crocker J. Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease. J Pathol 1992; 166: 1–5
   PubMed Web of Science ®Google Scholar
• Armstrong A A, Alexander F E, Paes R P, Morad N A, Gallagher A, Krajewski A S, et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993; 142: 1683–1688
   PubMed Web of Science ®Google Scholar
• Glavina-Durdov M, Jakic-Razumovic J, Capkun V, Murray P. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease. Br J Cancer 2001; 84: 1227–1234
   PubMed Web of Science ®Google Scholar
• Stark G L, Wood K M, Jack F, Angus B, Proctor S J, Taylor P R. Northern Region Lymphoma Group. Hodgkin's disease in the elderly: a population-based study. Br J Haematol 2002; 119: 432–440
   PubMed Web of Science ®Google Scholar
• Flavell K J, Billingham L J, Biddulph J P, Gray L, Flavell J R, Constandinou C M, et al. The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease. Ann Oncol 2003; 14: 282–290
   PubMed Web of Science ®Google Scholar
• Vestlev P M, Pallesen G, Sandvej K, Hamilton-Dutoit S J, Bendtzen S M. Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein. Int J Cancer 1992; 50: 670–671
   PubMed Web of Science ®Google Scholar
• Lauritzen A F, Hording U, Nielsen H W. Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study. APMIS 1994; 102: 495–500
   PubMed Web of Science ®Google Scholar
• Kanavaros P, Jiwa M, van der Valk P, Walboomers J, Horstman A, Meijer C J. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Hum Pathol 1993; 24: 725–729
   PubMed Web of Science ®Google Scholar
• van Gorp J, Jacobse K C, Broekhuizen R, Alers J, van den Tweel J G, de Weger R A. Encoded latent membrane protein 1 of Epstein-Barr virus on follicular dendritic cells in residual germinal centres in Hodgkin's disease. J Clin Pathol 1994; 47: 29–32
   PubMed Web of Science ®Google Scholar
• Morente M M, Piris M A, Abraira V, Acevedo A, Aguilera B, Bellas C, et al. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood 1997; 90: 2429–2436
   PubMed Web of Science ®Google Scholar
• Kanavaros P, Sakalidou A, Tzardi M, Darivianaki K, Delides G, Kazlaris E, et al. Frequent detection of Epstein-Barr virus (EBV), EBER transcripts and latent membrane protein-1 (LMP-1) in tumor cells in Hodgkin's disease arising in childhood. Pathol Res Pract 1994; 190: 1026–1030
   PubMed Web of Science ®Google Scholar
• Gulley M L, Glaser S L, Craig F E, Borowitz M, Mann R B, Shema S J, et al. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol 2002; 117: 259–267
   PubMed Web of Science ®Google Scholar
• Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, et al. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study. Mod Pathol 2003; 16: 566–573
   PubMed Web of Science ®Google Scholar
• Glaser S L, Lin R J, Stewart S L, Ambinder R F, Jarrett R F, Brousset P, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997; 70: 375–382
   PubMed Web of Science ®Google Scholar
• Jarrett R F, Gallagher A, Jones D B, Alexander F E, Krajewski A S, Kelsey A, et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol 1991; 44: 844–848
   PubMed Web of Science ®Google Scholar
• Jarrett R F, MacKenzie J. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease. Semin Hematol 1999; 36: 260–269
   PubMed Web of Science ®Google Scholar
• Lamy M E, Favart A M, Cornu C, Mendez M, Segas M, Burtonboy G. Study of Epstein Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti-EA and Ig anti-EBNA obtained with an original microtiter technique: serological criterions of primary and recurrent EBV infections and follow-up of infectious mononucleosis-seroepidemiology of EBV in Belgium based on 5178 sera from patients. Acta Clin Belg 1982; 37: 281–298
   PubMed Web of Science ®Google Scholar
• Huh J, Park C, Juhng S, Kim C E, Poppema S, Kim C. A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection. Cancer 1996; 77: 949–955
   PubMed Web of Science ®Google Scholar
• Murray P G, Billingham L J, Hassen H T, Flavell J R, Nelson P N, Scott K, et al. Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood 1999; 94: 442–447
   PubMed Web of Science ®Google Scholar
• Jarrett R F, Stark G L, White J, Angus B, Alexander F E, Krajewski A S, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classical Hodgkin lymphoma: a population-based study. Blood 2005; 106: 2444–2451
   PubMed Web of Science ®Google Scholar